Krensavage Asset Management’s Sanofi SNY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$15.6M Hold
323,946
6.1% 6
2025
Q4
$15.7M Hold
323,946
5.54% 7
2025
Q3
$15.3M Buy
323,946
+175,000
+117% +$8.45M 6.51% 7
2025
Q2
$7.2M Sell
148,946
-150
-0.1% -$7.66K 3.81% 11
2025
Q1
$8.27M Sell
149,096
-100
-0.1% -$5.41K 4.57% 9
2024
Q4
$7.2M Sell
149,196
-1,009
-0.7% -$51.3K 4.26% 9
2024
Q3
$8.66M Sell
150,205
-3,627
-2% -$196K 4.85% 8
2024
Q2
$7.46M Buy
153,832
+2,873
+2% +$139K 3.43% 10
2024
Q1
$7.34M Buy
150,959
+559
+0.4% +$27.3K 3.25% 10
2023
Q4
$7.48M Buy
+150,400
New +$7.35M 2.65% 9

Other funds holding SNY

Krensavage Asset Management's SNY Position: Q1 2026 in Review

Krensavage Asset Management held its Sanofi (SNY) position steady in Q1 2026 at 323,946 shares worth $15.6M. The position accounts for 6.1% of the portfolio, ranked #6.

Krensavage Asset Management first reported a position in SNY in Q4 2023 and has held it in 10 quarters since. The position peaked at $15.7M in Q4 2025. 739 funds tracked by Wall St. Rank hold SNY as of Q1 2026.

  • Krensavage Asset Management held 323,946 shares of Sanofi worth $15.6M as of Q1 2026.
  • Krensavage Asset Management left its Sanofi share count unchanged in Q1 2026.
  • Sanofi made up 6.1% of Krensavage Asset Management's portfolio in Q1 2026, its #6 holding.
  • Krensavage Asset Management first reported a position in Sanofi in Q4 2023 and has held it in 10 quarters since.
  • Krensavage Asset Management's Sanofi position peaked at $15.7M in Q4 2025.
  • 739 funds tracked by Wall St. Rank held Sanofi as of Q1 2026.

Based on Krensavage Asset Management's 13F filing for Q1 2026, filed 15 May 2026.